ECIA
Encision Inc.
Price Chart
Latest Quote
$0.00
+0.00 (+0.00%)
Current Price
| Previous Close | $0.00 |
| Open | $0.20 |
| Day High | $0.20 |
| Day Low | $0.20 |
| Volume | 13,357 |
Stock Information
| Shares Outstanding | 16.88M |
| Revenue | $6.30M |
| Net Income | $-381K |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $25K |
| EPS (TTM) | $-0.03 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Sales | $6.30M |
| Income | $-381K |
| Book/sh | $0.14 |
| Employees | 22 |
Financial Ratios
| Quick Ratio | 0.78 |
| Current Ratio | 2.28 |
| EPS Growth TTM | -70.00% |
Returns & Margins
| ROA | -5.27% |
| ROE | -21.36% |
| Gross Margin | 52.64% |
| Operating Margin | -4.15% |
| Profit Margin | -6.05% |
Ownership
| Insider Ownership | 64.04% |
| Institutional Ownership | 5.72% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| PEG | 1.42 |
| P/S | 0.00 |
| P/B | 0.01 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.02 |
| SMA50 | $0.12 |
| SMA200 | $0.19 |
| RSI | 100.00 |
| ATR | 0.0001 |
| Shares Float | 3.52M |
| Short Ratio | 0.49 |
| Volatility | 0.98 |
Performance History
| Week | +400.00% |
| Month | -99.25% |
| Quarter | -98.75% |
| 6 Months | -99.01% |
| YTD | -98.93% |
| Year | -99.54% |
| 3 Years | -99.62% |
| 5 Years | -99.85% |
| 10 Years | -99.61% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.00 | 0 |
| 2026-06-17 | $0.00 | 0 |
| 2026-06-16 | $0.00 | 0 |
| 2026-06-15 | $0.00 | 160 |
| 2026-06-12 | $0.00 | 9,000 |
| 2026-06-11 | $0.00 | 0 |
| 2026-06-10 | $0.00 | 0 |
| 2026-06-09 | $0.00 | 0 |
| 2026-06-08 | $0.00 | 0 |
| 2026-06-05 | $0.00 | 5,000 |
| 2026-06-04 | $0.00 | 0 |
| 2026-06-03 | $0.00 | 0 |
| 2026-06-02 | $0.00 | 0 |
| 2026-06-01 | $0.00 | 0 |
| 2026-05-29 | $0.00 | 0 |
| 2026-05-28 | $0.00 | 0 |
| 2026-05-27 | $0.00 | 0 |
| 2026-05-26 | $0.00 | 12,899 |
| 2026-05-22 | $0.20 | 0 |
| 2026-05-21 | $0.20 | 0 |
| 2026-05-20 | $0.20 | 0 |
| 2026-05-19 | $0.20 | 0 |
About Encision Inc.
Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. It operates through two segments, Product and Service. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. The AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. It also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; AEM EndoShield 2 burn protection systems; AEM 2X enTouch scissors; and electrical engineering activities for external entities. In addition, the company markets AEM monitor product line that is used in conjunction with AEM instruments. It sells its products through a network of direct and independent sales representatives. The company was formerly known as Electroscope Inc and changed its name to Encision Inc. in August 2000. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.
đ° Latest News
No news articles available at the moment. Check back later for updates on ECIA.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $3,044,029 | $3,449,920 | $3,315,981 | $3,880,218 |
| Cost Of Revenue | $3,044,029 | $3,449,920 | $3,315,981 | $3,880,218 |
| Total Revenue | $6,555,315 | $6,585,882 | $7,348,514 | $7,668,636 |
| Operating Revenue | $6,555,315 | $6,585,882 | $7,348,514 | $7,668,636 |
| Expenses | ||||
| Interest Expense | $43,723 | $62,373 | $19,529 | $7,224 |
| Total Expenses | $6,727,295 | $7,226,665 | $7,651,311 | $8,263,570 |
| Other Income Expense | $-4,495 | $11,373 | $-1,619 | $536,564 |
| Other Non Operating Income Expenses | $-4,495 | $11,373 | $-1,619 | $3,446 |
| Net Non Operating Interest Income Expense | $-43,723 | $-62,373 | $-19,529 | $-7,224 |
| Interest Expense Non Operating | $43,723 | $62,373 | $19,529 | $7,224 |
| Operating Expense | $3,683,266 | $3,776,745 | $4,335,330 | $4,383,352 |
| Selling And Marketing Expense | $1,689,503 | $1,634,124 | $2,032,415 | $2,084,110 |
| General And Administrative Expense | $1,400,611 | $1,520,727 | $1,486,796 | $1,381,087 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-220,198 | $-691,783 | $-323,945 | $-65,594 |
| Net Interest Income | $-43,723 | $-62,373 | $-19,529 | $-7,224 |
| Normalized Income | $-220,198 | $-691,783 | $-323,945 | $-598,712 |
| Net Income From Continuing And Discontinued Operation | $-220,198 | $-691,783 | $-323,945 | $-65,594 |
| Total Operating Income As Reported | $-171,980 | $-640,783 | $-302,797 | $-594,934 |
| Net Income Common Stockholders | $-220,198 | $-691,783 | $-323,945 | $-65,594 |
| Net Income | $-220,198 | $-691,783 | $-323,945 | $-65,594 |
| Net Income Including Noncontrolling Interests | $-220,198 | $-691,783 | $-323,945 | $-65,594 |
| Net Income Continuous Operations | $-220,198 | $-691,783 | $-323,945 | $-65,594 |
| Pretax Income | $-220,198 | $-691,783 | $-323,945 | $-65,594 |
| Operating Income | $-171,980 | $-640,783 | $-302,797 | $-594,934 |
| Gross Profit | $3,511,286 | $3,135,962 | $4,032,533 | $3,788,418 |
| Special Income Charges | - | - | $0 | $533,118 |
| Per Share | ||||
| Diluted EPS | $-0.02 | $-0.06 | $-0.03 | $-0.01 |
| Basic EPS | $-0.02 | $-0.06 | $-0.03 | $-0.01 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-95,082 | $-544,192 | $-217,510 | $-478,018 |
| Reconciled Depreciation | $81,393 | $85,218 | $86,906 | $113,470 |
| EBITDA (Bullshit earnings) | $-95,082 | $-544,192 | $-217,510 | $55,100 |
| EBIT | $-176,475 | $-629,410 | $-304,416 | $-58,370 |
| Diluted Average Shares | $11,879,645 | $11,770,000 | $11,763,000 | $11,625,000 |
| Basic Average Shares | $11,879,645 | $11,770,000 | $11,763,000 | $11,625,000 |
| Diluted NI Availto Com Stockholders | $-220,198 | $-691,783 | $-323,945 | $-65,594 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Research And Development | $593,152 | $621,894 | $816,119 | $918,155 |
| Selling General And Administration | $3,090,114 | $3,154,851 | $3,519,211 | $3,465,197 |
| Other Gand A | $1,400,611 | $1,520,727 | $1,486,796 | $1,381,087 |
| Total Unusual Items | - | - | $0 | $533,118 |
| Total Unusual Items Excluding Goodwill | - | - | $0 | $533,118 |
| Other Special Charges | - | - | - | $-533,118 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $1,479,212 | $1,662,738 | $2,331,678 | $2,565,145 |
| Total Assets | $3,670,699 | $3,810,716 | $4,133,969 | $4,792,385 |
| Total Non Current Assets | $1,057,934 | $1,384,442 | $1,009,366 | $1,190,663 |
| Other Non Current Assets | $72,892 | $65,641 | $46,953 | $34,240 |
| Goodwill And Other Intangible Assets | $171,890 | $164,010 | $163,133 | $180,719 |
| Other Intangible Assets | $171,890 | $164,010 | $163,133 | $180,719 |
| Current Assets | $2,612,765 | $2,426,274 | $3,124,603 | $3,601,722 |
| Other Current Assets | $85,679 | $90,298 | $115,714 | - |
| Inventory | $1,483,182 | $1,402,338 | $1,899,202 | $1,584,321 |
| Receivables | $786,471 | $891,129 | $920,721 | $947,623 |
| Accounts Receivable | $786,471 | $891,129 | $920,721 | $947,623 |
| Cash Cash Equivalents And Short Term Investments | $257,433 | $42,509 | $188,966 | $949,645 |
| Cash And Cash Equivalents | $257,433 | $42,509 | $188,966 | $949,645 |
| Cash Financial | $257,433 | $42,509 | $188,966 | $949,645 |
| Prepaid Assets | - | - | $115,714 | $120,133 |
| Allowance For Doubtful Accounts Receivable | - | - | - | $0 |
| Gross Accounts Receivable | - | - | - | $947,623 |
| Debt | ||||
| Net Debt | $360,129 | $223,706 | $301,439 | - |
| Total Debt | $1,314,172 | $1,333,202 | $1,083,899 | $1,154,108 |
| Long Term Debt And Capital Lease Obligation | $443,682 | $915,631 | $508,332 | $770,130 |
| Long Term Debt | $177,470 | $219,021 | $268,512 | $205,809 |
| Current Debt And Capital Lease Obligation | $870,490 | $417,571 | $575,567 | $383,978 |
| Current Debt | $440,092 | $47,194 | $221,893 | $21,491 |
| Other Current Borrowings | $44,128 | $47,194 | $44,491 | $21,491 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,019,597 | $1,983,968 | $1,639,158 | $2,046,521 |
| Total Non Current Liabilities Net Minority Interest | $443,682 | $915,631 | $508,332 | $770,130 |
| Current Liabilities | $1,575,915 | $1,068,337 | $1,130,826 | $1,276,391 |
| Current Deferred Liabilities | $44,771 | $0 | - | - |
| Payables And Accrued Expenses | $479,804 | $465,853 | $337,535 | $701,560 |
| Payables | $392,985 | $406,234 | $282,609 | $644,346 |
| Total Tax Payable | $46,085 | $60,185 | $29,652 | $67,965 |
| Accounts Payable | $346,900 | $346,049 | $252,957 | $576,381 |
| Equity | ||||
| Common Stock Equity | $1,651,102 | $1,826,748 | $2,494,811 | $2,745,864 |
| Total Equity Gross Minority Interest | $1,651,102 | $1,826,748 | $2,494,811 | $2,745,864 |
| Stockholders Equity | $1,651,102 | $1,826,748 | $2,494,811 | $2,745,864 |
| Retained Earnings | $-22,765,245 | $-22,545,047 | $-21,853,264 | $-21,529,319 |
| Other | ||||
| Ordinary Shares Number | $11,879,645 | $11,858,627 | $11,769,543 | $11,719,543 |
| Share Issued | $11,879,645 | $11,858,627 | $11,769,543 | $11,719,543 |
| Tangible Book Value | $1,479,212 | $1,662,738 | $2,331,678 | $2,565,145 |
| Invested Capital | $2,268,664 | $2,092,963 | $2,985,216 | $2,973,164 |
| Working Capital | $1,036,850 | $1,357,937 | $1,993,777 | $2,325,331 |
| Capital Lease Obligations | $696,610 | $1,066,987 | $593,494 | $926,808 |
| Total Capitalization | $1,828,572 | $2,045,769 | $2,763,323 | $2,951,673 |
| Capital Stock | $24,416,347 | $24,371,795 | $24,348,075 | $24,275,183 |
| Common Stock | $24,416,347 | $24,371,795 | $24,348,075 | $24,275,183 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $266,212 | $696,610 | $239,820 | $564,321 |
| Current Deferred Revenue | $44,771 | $0 | - | - |
| Current Capital Lease Obligation | $430,398 | $370,377 | $353,674 | $362,487 |
| Line Of Credit | $395,964 | $0 | $177,402 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $180,850 | $184,913 | $217,724 | $190,853 |
| Current Accrued Expenses | $86,819 | $59,619 | $54,926 | $57,214 |
| Net PPE | $813,152 | $1,154,791 | $799,280 | $975,704 |
| Accumulated Depreciation | $-2,340,689 | $-2,373,722 | $-2,312,400 | $-2,279,652 |
| Gross PPE | $3,153,841 | $3,528,513 | $3,111,680 | $3,255,356 |
| Other Properties | $568,395 | $900,787 | $496,004 | $786,407 |
| Machinery Furniture Equipment | $2,585,446 | $2,627,726 | $2,615,676 | $2,468,949 |
| Finished Goods | $389,652 | $358,177 | $474,836 | $536,934 |
| Raw Materials | $1,093,530 | $1,044,161 | $1,424,366 | $1,083,387 |
| Treasury Shares Number | - | $0 | - | - |
| Inventories Adjustments Allowances | - | - | $-51,000 | $-36,000 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-134,973 | $107,566 | $-1,044,784 | $-479,833 |
| Operating Activities | ||||
| Operating Cash Flow | $-54,948 | $144,389 | $-861,485 | $-444,432 |
| Cash Flow From Continuing Operating Activities | $-54,948 | $144,389 | $-861,485 | $-444,432 |
| Operating Gains Losses | - | - | - | $-533,118 |
| Investing Activities | ||||
| Capital Expenditure | $-80,025 | $-36,823 | $-183,299 | $-35,401 |
| Investing Cash Flow | $-80,025 | $-36,823 | $-183,299 | $-35,401 |
| Cash Flow From Continuing Investing Activities | $-80,025 | $-36,823 | $-183,299 | $-35,401 |
| Capital Expenditure Reported | $-25,610 | $-24,773 | $-10,030 | $-17,851 |
| Financing Activities | ||||
| Financing Cash Flow | $349,897 | $-254,023 | $284,105 | $-44,861 |
| Cash Flow From Continuing Financing Activities | $349,897 | $-254,023 | $284,105 | $-44,861 |
| Other | ||||
| Interest Paid Supplemental Data | $43,723 | $62,373 | $19,529 | $7,224 |
| End Cash Position | $257,433 | $42,509 | $188,966 | $949,645 |
| Beginning Cash Position | $42,509 | $188,966 | $949,645 | $1,474,339 |
| Changes In Cash | $214,924 | $-146,457 | $-760,679 | $-524,694 |
| Proceeds From Stock Option Exercised | $-1,449 | $-29,833 | $21,000 | $-31,501 |
| Net Issuance Payments Of Debt | $351,346 | $-224,190 | $263,105 | $-13,360 |
| Net Short Term Debt Issuance | $395,964 | $-177,402 | $239,752 | $0 |
| Net Long Term Debt Issuance | $-44,618 | $-46,788 | $23,353 | $-13,360 |
| Net Intangibles Purchase And Sale | $-25,610 | $-24,773 | $-10,030 | $-17,851 |
| Purchase Of Intangibles | $-25,610 | $-24,773 | $-10,030 | $-17,851 |
| Net PPE Purchase And Sale | $-54,415 | $-12,050 | $-173,269 | $-17,550 |
| Purchase Of PPE | $-54,415 | $-12,050 | $-173,269 | $-17,550 |
| Change In Working Capital | $32,936 | $685,402 | $-691,338 | $37,957 |
| Change In Other Current Assets | $-37,985 | $68,710 | $-42,912 | $-28,414 |
| Change In Payables And Accrued Expense | $54,659 | $95,506 | $-337,153 | $39,537 |
| Change In Accrued Expense | $36,407 | $2,414 | $-13,730 | $-147,756 |
| Change In Payable | $18,252 | $93,092 | $-323,423 | $187,293 |
| Change In Account Payable | $18,252 | $93,092 | $-323,423 | $187,293 |
| Change In Prepaid Assets | $-2,632 | $6,728 | $-8,294 | $-31,435 |
| Change In Inventory | $-85,764 | $484,866 | $-329,881 | $-105,187 |
| Change In Receivables | $104,658 | $29,592 | $26,902 | $163,456 |
| Changes In Account Receivables | $104,658 | $29,592 | $26,902 | $163,456 |
| Stock Based Compensation | $46,001 | $53,552 | $51,892 | $40,853 |
| Provisionand Write Offof Assets | $4,920 | $12,000 | $15,000 | $-69,000 |
| Depreciation Amortization Depletion | $81,393 | $85,218 | $86,906 | $113,470 |
| Depreciation And Amortization | $81,393 | $85,218 | $86,906 | $113,470 |
| Net Income From Continuing Operations | $-220,198 | $-691,783 | $-323,945 | $-65,594 |
| Issuance Of Debt | - | - | $263,105 | $0 |
| Short Term Debt Issuance | - | - | $239,752 | $0 |
| Long Term Debt Issuance | - | - | $23,353 | $0 |
| Change In Other Working Capital | - | - | $-13,730 | $-147,756 |
| Asset Impairment Charge | - | - | $0 | $31,000 |
| Repayment Of Debt | - | - | - | $-13,360 |
| Long Term Debt Payments | - | - | - | $-13,360 |
| Other Non Cash Items | - | - | - | - |
Fetched: 2026-02-02